KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Operating Margin (2016 - 2025)

Amgen has reported Operating Margin over the past 17 years, most recently at 27.57% for Q4 2025.

  • Quarterly results put Operating Margin at 27.57% for Q4 2025, up 213.0% from a year ago — trailing twelve months through Dec 2025 was 24.71% (up 299.0% YoY), and the annual figure for FY2025 was 24.71%, up 299.0%.
  • Operating Margin for Q4 2025 was 27.57% at Amgen, up from 26.43% in the prior quarter.
  • Over the last five years, Operating Margin for AMGN hit a ceiling of 485.84% in Q4 2022 and a floor of 12.69% in Q2 2021.
  • Median Operating Margin over the past 5 years was 29.11% (2023), compared with a mean of 50.72%.
  • Biggest five-year swings in Operating Margin: skyrocketed 45218bps in 2022 and later plummeted -47033bps in 2023.
  • Amgen's Operating Margin stood at 33.65% in 2021, then soared by 1344bps to 485.84% in 2022, then tumbled by -97bps to 15.51% in 2023, then soared by 64bps to 25.43% in 2024, then increased by 8bps to 27.57% in 2025.
  • The last three reported values for Operating Margin were 27.57% (Q4 2025), 26.43% (Q3 2025), and 28.94% (Q2 2025) per Business Quant data.